| 1 |
中国医疗保健国际交流促进会胃食管反流病学分会. 中国胃食管反流病多学科诊疗共识2022(一) [J/OL]. 中华胃食管反流病电子杂志, 2022, 9(2): 51-86.
|
| 2 |
Ordás I, Eckmann L, Talamini M, et al. Ulcerative colitis [J]. Lancet, 2012, 380(9843): 1606-1619.
|
| 3 |
Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee [J]. Am J Gastroenterol, 2010, 105(3): 501-523.
|
| 4 |
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease [J]. Am J Gastroenterol, 2013, 108(3): 308-328.
|
| 5 |
艾合麦提·喀斯木, 买买提·依斯热依力, 克力木·阿布都热依木. 肠道菌群在胃食管反流病发病中的作用及相关性研究进展 [J]. 中国医师杂志, 2022, 24(8): 1273-1276.
|
| 6 |
Wang X, Almetwali O, Wang J, et al. Enhanced risk of gastroesophageal reflux disease and esophageal complications in the ulcerative colitis population [J]. J Clin Med, 2024, 13(16): 4783.
|
| 7 |
He YX, Li YY, Wu YQ, et al. Huanglian Ganjiang decoction alleviates ulcerative colitis by restoring gut barrier via APOC1-JNK/P38 MAPK signal pathway based on proteomic analysis [J]. J Ethnopharmacol, 2024, 318: 116994.
|
| 8 |
Wang J, Lv X, Li Y, et al. A ROS-responsive hydrogel that targets inflamed mucosa to relieve ulcerative colitis by reversing intestinal mucosal barrier loss [J]. J Control Release, 2025, 377: 606-618.
|
| 9 |
钟玉婷, 王志斌, 张立超. 天然小分子保护炎症性肠病中肠上皮紧密连接屏障的研究进展 [J]. 中国药理学通报, 2023, 39(12): 2205-2210.
|
| 10 |
依力汗·依明, 艾克拜尔·艾力, 买买提·依斯热依力. 炎症因子及炎症反应在胃食管反流病发病机制中作用的研究进展 [J]. 国际免疫学杂志, 2022, 45(3): 321-325.
|
| 11 |
Altomare A. Gastroesophageal reflux disease: update on inflammation and symptom perception [J]. World J Gastroenterol, 2013, 19(39): 6523-6528.
|
| 12 |
Wei J, Feng J. Signaling pathways associated with inflammatory bowel disease [J]. Recent Pat Inflamm Allergy Drug Discov, 2010, 4(2): 105-117.
|
| 13 |
Mukherjee T, Kumar N, Chawla M, et al. The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease [J]. Sci Signal, 2023, 17(818): eadh1641.
|
| 14 |
Patel M, Valaiyaduppu Subas S, Ghani MR, et al. Role of substance P in the pathophysiology of inflammatory bowel disease and its correlation with the degree of inflammation [J]. Cureus, 2020, 12(10): e11027.
|
| 15 |
涂严平. 基于脑肠肽探讨胃食管反流病的发病机制 [J]. 大众科技, 2022, 24(12): 114-118..
|
| 16 |
崔剑昱, 艾克拜尔·艾力, 克力木·阿不都热依木, 等. 肠道菌群和胃食管反流病发病的相关性 [J/OL]. 中华胃食管反流病电子杂志, 2022, 9(1): 39-43.
|
| 17 |
Deloose E, Janssen P, Depoortere I, et al. The migrating motor complex: control mechanisms and its role in health and disease [J]. Nat Rev Gastroenterol Hepatol, 2012, 9(5): 271-285.
|
| 18 |
Naito Y, Takagi T. Role of gut microbiota in inflammatory bowel disease pathogenesis [J]. J Clin Biochem Nutr, 2024, 75(3): 175-177.
|
| 19 |
Hu Y, Chen Z, Xu C, et al. Disturbances of the gut microbiota and microbiota-derived metabolites in inflammatory bowel disease [J]. Nutrients, 2022, 14(23): 5140.
|
| 20 |
Cammarota G, Ianiro G, Cianci R, et al. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy [J]. Pharmacol Ther, 2015, 149: 191-212.
|
| 21 |
Clemente JC, Ursell LK, Parfrey LW, et al. The impact of the gut microbiota on human health: an integrative view [J]. Cell, 2012, 148(6): 1258-1270.
|
| 22 |
李莹莹, 纪巧荣. 肠道菌群及其代谢物短链脂肪酸与肠黏膜免疫关系的研究进展 [J]. 微生物免疫学进展, 2023, 51(6): 67-73.
|
| 23 |
Hu Y, Chen Z, Xu C, et al. Disturbances of the gut microbiota and microbiota-derived metabolites in inflammatory bowel disease [J]. Nutrients, 2022, 14(23): 5140.
|
| 24 |
Mentella MC, Scaldaferri F, Pizzoferrato M, et al. Nutrition, IBD and gut microbiota: a review [J]. Nutrients, 2020, 12(4): 944.
|
| 25 |
Owczarek D. Diet and nutritional factors in inflammatory bowel diseases [J]. World J Gastroenterol, 2016, 22(3): 895.
|
| 26 |
Kawano Y, Edwards M, Huang Y, et al. Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome [J]. Cell, 2022, 185(19): 3501-3519.e20.
|
| 27 |
彭献镇, 谈雨嘉, 韩楚昆, 等. 胃食管反流病与饮食习惯的相关性分析 [J]. 中文科技期刊数据库（文摘版）医药卫生, 2022(6): 13-15
|
| 28 |
袁玲芝, 唐丹, 彭进, 等. 针对胃食管反流病患者不良生活习惯的调查研究 [J]. 中南大学学报(医学版), 2017, 42(5): 558-564.
|
| 29 |
Morozov S, Isakov V, Konovalova M. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease [J]. World J Gastroenterol, 2018, 24(21): 2291-2299.
|
| 30 |
Martínez-Vázquez SE, Corral-Ceballos JM, Yamamoto-Furusho JK. Correlation between the quantity and type of dietary fiber with the activity in mexican patients with ulcerative colitis (UC) [J]. Nutrients, 2024, 16(18): 3198.
|
| 31 |
Ribichini E, Scalese G, Mocci C, et al. Gut–brain axis and psychopathology: exploring the impact of diet with a focus on the low-FODMAP approach [J]. Nutrients, 2024, 16(20): 3515.
|
| 32 |
中国医疗保健国际交流促进会胃食管反流病学分会, 吴继敏, 汪忠镐, 等. 中国胃食管反流病多学科诊疗共识2022(二) [J/OL]. 中华胃食管反流病电子杂志, 2022, 9(3): 112-146
|
| 33 |
Sun LJ, Li JN, Nie YZ. Gut hormones in microbiota-gut-brain cross-talk [J]. Chin Med J (Engl), 2020, 133(7): 826-833.
|
| 34 |
Keefer L, Taft TH, Kiebles JL, et al. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis [J]. Aliment Pharmacol Ther, 2013, 38(7): 761-771.
|
| 35 |
中华医学会消化病学分会炎症性肠病学组, 中国炎症性肠病诊疗质量控制评估中心. 中国溃疡性结肠炎诊治指南(2023年·西安) [J]. 胃肠病学, 2024, 29(3): 145-173.
|
| 36 |
Filaretova L, Podvigina T, Yarushkina N. Physiological and pharmacological effects of glucocorticoids on the gastrointestinal tract [J]. Curr Pharm Des, 2020, 26(25): 2962-2970.
|
| 37 |
Wells JM, Brummer RJ, Derrien M, et al. Homeostasis of the gut barrier and potential biomarkers [J]. Am J Physiol Gastrointest Liver Physiol, 2017, 312(3): G171-G193.
|
| 38 |
Stack WA, Williams D, Stevenson M, et al. Immunosuppressive therapy for ulcerative colitis: results of a nation-wide survey among consultant physician members of the British Society of Gastroenterology [J]. Aliment Pharmacol Ther, 1999, 13(5): 569-575.
|
| 39 |
孙元曦, 宫珍, 官波. 免疫抑制剂治疗对机体微生态的影响及预防措施 [J]. 山东医药, 2008, 48(44): 112-113.
|
| 40 |
Kroch DA, Madanick RD. Medical treatment of gastroesophageal reflux disease [J]. World J Surg, 2017, 41(7): 1678-1684.
|
| 41 |
Xia B, Yang M, Nguyen LH, et al. Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of 3 prospective cohorts [J]. Gastroenterology, 2021, 161(6): 1842-1852. e10.
|
| 42 |
Liang Y, Meng Z, Ding XL, et al. Effects of proton pump inhibitors on inflammatory bowel disease: an updated review [J]. World J Gastroenterol, 2024, 30(21): 2751-2762.
|
| 43 |
周铖, 孙鹏飞, 解昕轶, 等. 质子泵抑制剂对消化道菌群组成变化的相关性研究进展 [J]. 南京医科大学学报(自然科学版), 2020, 40(9): 1386-1390, 1402.
|
| 44 |
Choden T, Zhang H, Sakuraba A. Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease [J]. Ann Med, 2023, 55(1): 2198775.
|
| 45 |
Wei W, Yan P, Wang F, et al. Malnutrition defined by the global leadership initiative on malnutrition (GLIM) criteria in hospitalized patients with ulcerative colitis and its association with clinical outcomes [J]. Nutrients, 2023, 15(16): 3572.
|
| 46 |
Pulley J, Todd A, Flatley C, et al. Malnutrition and quality of life among adult inflammatory bowel disease patients [J]. JGH Open, 2020, 4(3): 454-460.
|
| 47 |
Welsh FKS, Farmery SM, MacLennan K, et al. Gut barrier function in malnourished patients [J]. Gut, 1998, 42(3): 396-401.
|
| 48 |
Wu P, Zhao XH, Ai ZS, et al. Dietary intake and risk for reflux esophagitis: a case-control study [J]. Gastroenterol Res Pract, 2013, 2013: 691026.
|
| 49 |
刘志华, 黄南祺, 李超, 等. 短肠综合征的手术治疗进展 [J]. 中华消化外科杂志, 2014, 13(2): 157-160.
|
| 50 |
黄雨桦. 短肠综合征肠道菌群变化特点及其在肠衰竭相关性肝损害发病中的作用研究[D]. 南京: 南京大学, 2017.
|
| 51 |
Brzozowski B, Mazur-Bialy A, Pajdo R, et al. Mechanisms by which stress affects the experimental and clinical inflammatory bowel disease (IBD): role of brain-gut axis [J]. Curr Neuropharmacol, 2016, 14(8): 892-900.
|
| 52 |
Kauppi J, Räsänen J, Sihvo E, et al. Increased oxidative stress in the proximal stomach of patients with Barrett’s esophagus and adenocarcinoma of the esophagus and esophagogastric junction [J]. Transl Oncol, 2016, 9(4): 336-339.
|
| 53 |
Sihvo EIT, Ruohtula T, Auvinen MI, et al. Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus [J]. J Thorac Cardiovasc Surg, 2003, 126(6): 1952-1957.
|
| 54 |
Rana SV, Sharma S, Prasad KK, et al. Role of oxidative stress & antioxidant defence in ulcerative colitis patients from North India [J]. Indian J Med Res, 2014, 139(4): 568-571.
|
| 55 |
Krzystek-Korpacka M, Kempiński R, Bromke MA, et al. Oxidative stress markers in inflammatory bowel diseases: systematic review [J]. Diagnostics (Basel), 2020, 10(8): 601.
|